TRNGF OTC

The Trendlines Group Ltd. operates as a dynamic private equity and venture capital firm, primarily focused on fostering and bringing innovative technologies to market. They strategically invest across the entire venture spectrum, from initial incubation and seed funding through early and late-stage development. The firm's investment interests span critical sectors including food, cleantech, agritechnology, and life sciences—specifically targeting medical devices, biotechnology, and pharmaceuticals—alongside security and information technology enterprises. Geographically, they concentrate their search for promising ventures in Israel and Singapore. Beyond providing capital, Trendlines offers extensive hands-on support to its entrepreneurs. This comprehensive suite of services includes business incubation, strategic partner and channel development, market strategy crafting, business planning, R&D and commercialization guidance, business development, financial and funding advisory, administrative assistance, and marketing communications. They typically seek to deploy a minimum of $60,000 into each portfolio company. Preferred exit strategies include mergers and acquisitions (M&A), public listings, or other strategic dispositions of holdings. To mitigate risk in new business ventures, Trendlines co-invests its own capital with government funding. Their engagement is deep and comprehensive, encompassing every facet of their portfolio companies, from technological advancement to robust business building. Established in 1993, the company maintains its primary base in M.P. Misgav, Israel, complemented by additional offices in Tel Aviv, Israel; Beijing, China; and Singapore.